Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States
- PMID: 31002830
- DOI: 10.1016/j.ypmed.2019.04.010
Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States
Abstract
Recent trends of cervical cancer incidence by histology and age in the United States (U.S.) have not been reported. We examined contemporary trends in cervical squamous cell carcinoma (SCC) and adenocarcinoma (AC) incidence rates in the U.S. by age group, race/ethnicity, and stage at diagnosis after accounting for hysterectomy. Incidence data (1999-2015) were obtained from the U.S. Cancer Statistics Incidence Analytic Database. Hysterectomy prevalence was estimated using National Health Interview Survey data (2000-2015). Overall SCC incidence rates continued to decrease in all racial/ethnic groups except among non-Hispanic whites in whom rates stabilized in the 2010s, largely driven by stable trends in ages <50 years and a slower pace of decrease in ages 50-59 years. After a stable trend between 1999 and 2002, AC incidence rates among non-Hispanic whites rose during 2002-2015 (1.3% per year), mostly due to increases in ages 40-49 (4.4% annually since 2004) and 50-59 years (5.5% annually since 2011). Overall AC incidence rates during 1999-2015 decreased in blacks and Hispanics but were stable in Asian/Pacific Islanders; in all these race/ethnicities, rates were generally stable in ages <50 years but decreasing in older ages. Rates of distant stage cervical SCC and AC among non-Hispanic whites increased in several age groups but were generally stable in non-whites. Increasing or stabilized incidence trends for AC and attenuation of earlier declines for SCC in several subpopulations underscore the importance of intensifying efforts to reverse the increasing trends and further reduce the burden of cervical cancer in the U.S.
Keywords: Adenocarcinoma; Cervical cancer; Human papillomavirus; Screening; Squamous cell carcinoma.
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment in
-
Cervical cancer subtype less detectable by Papanicolaou testing.Cancer. 2019 Oct 1;125(19):3287. doi: 10.1002/cncr.32494. Cancer. 2019. PMID: 31518005 No abstract available.
Similar articles
-
Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.J Clin Oncol. 2019 Aug 1;37(22):1895-1908. doi: 10.1200/JCO.19.00151. Epub 2019 May 22. J Clin Oncol. 2019. PMID: 31116674 Free PMC article.
-
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.Cancer. 2004 Mar 1;100(5):1035-44. doi: 10.1002/cncr.20064. Cancer. 2004. PMID: 14983500
-
Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003.Cancer Causes Control. 2007 Dec;18(10):1175-86. doi: 10.1007/s10552-007-9056-y. Epub 2007 Sep 6. Cancer Causes Control. 2007. PMID: 17805982
-
The role of race/ethnicity in the epidemiology of esophageal cancer.J Assoc Acad Minor Phys. 2000;11(2-3):32-7. J Assoc Acad Minor Phys. 2000. PMID: 10953542 Review.
-
Epidemiologic trends in esophageal and gastric cancer in the United States.Surg Oncol Clin N Am. 2002 Apr;11(2):235-56. doi: 10.1016/s1055-3207(02)00002-9. Surg Oncol Clin N Am. 2002. PMID: 12424848 Review.
Cited by
-
Use of Nomogram to Predict the Risk of Lymph Node Metastasis among Patients with Cervical Adenocarcinoma.J Immunol Res. 2022 Aug 23;2022:6816456. doi: 10.1155/2022/6816456. eCollection 2022. J Immunol Res. 2022. PMID: 36052281 Free PMC article.
-
The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment.Nat Rev Clin Oncol. 2020 Oct;17(10):631-649. doi: 10.1038/s41571-020-0378-y. Epub 2020 May 28. Nat Rev Clin Oncol. 2020. PMID: 32467620 Review.
-
Olive: A Potential Suppressor for Cervical Cancer by Upregulation of P21.Cureus. 2023 May 8;15(5):e38719. doi: 10.7759/cureus.38719. eCollection 2023 May. Cureus. 2023. PMID: 37292535 Free PMC article.
-
Contemporary Review of Adenocarcinoma of the Cervix.Curr Treat Options Oncol. 2024 Dec;25(12):1538-1549. doi: 10.1007/s11864-024-01254-9. Epub 2024 Nov 13. Curr Treat Options Oncol. 2024. PMID: 39535688 Review.
-
FTO Facilitates Cervical Cancer Malignancy Through Inducing m6A-Demethylation of PIK3R3 mRNA.Cancer Med. 2024 Dec;13(24):e70507. doi: 10.1002/cam4.70507. Cancer Med. 2024. PMID: 39692250 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials